In the News Chicago Daily Law Bulletin

Abbott Wins in Patent Case Over DNA Tech

"Abbott Laboratories did not infringe a New York-based company’s patent on nucleic acid-detection technology because the supplier’s patent is invalid for not adequately explaining itself, a Delaware federal judge ruled.

The Lake County-based pharmaceutical company was represented in the case by a group of attorneys from Kirkland & Ellis LLP."

To read the full text of this article (subscription required) please click here.

This article appeared in its entirety in the August 23, 2017 edition of Chicago Daily Law Bulletin.